rss
Br J Ophthalmol 87:563-566 doi:10.1136/bjo.87.5.563
  • Scientific correspondence

Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy

Table 1

Clinical data of 18 eyes using PFCL for diabetic vitrectomy

Visual acuity
Case Age (years) Sex Eye Preoperative diagnosis Pre Post Follow up (months) Postoperative complication
F = female; M, male; LE = left eye; RE = right eye; PVR, proliferative vitreoretinopathy; MTRD, macular tractional retinal detachment; VH = vitreous haemorrhage; RRD/TRD = combined traction/rhegnatogenous retinal detachment; HM = hand movement; CF = counting fingers; LP = light perception; RAO = retinal artery occlusion; NVG = neovascular glaucoma.
1 66 F LE PVR+MTRD 20/200 NL 18 inoperable RD
2 50 M LE MTRD HM 20/400 16
3 60 F RE MTRD 20/200 20/60 16
LE VH+MTRD LP LP 15 RAO
4 69 M LE RRD/MTRD HM HM 16
5 28 M RE VH+MTRD CF 20/20 16
6 60 F RE MTRD LP 20/800 15
7 57 M RE VH+MTRD 20/400 LP 15
8 34 M RE MTRD 20/400 20/200 14
9 65 F RE MTRD HM 20/200 14
LE MTRD HM 20/200 13 subretinal PFCL
10 33 M RE VH+MTRD HM HM 12 NVG
LE MTRD HM NL 12 expulsive haemorrhage
11 58 M LE MTRD 20/400 20/40 12
12 61 F LE MTRD 20/30 20/40 11
13 37 M RE MTRD CF 20/30 10
14 65 M LE VH+MTRD 20/100 20/200 9
15 50 F RE RRD/TRD LP CF 6

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.